BRANDES INVESTMENT PARTNERS, LP

Position in OGN — Organon & Co.

CIK 1015079 LA JOLLA, CA

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,877,456

+$5,734,623 QoQ

Shares Held

729,502

+5.5% QoQ

Ownership

0.278%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#48

of 626 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRANDES INVESTMENT PARTNERS, LP holds $1,062,449,068 across 8 Drug Manufacturers - General names. OGN ranks #8 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GRFS	Grifols SA	37,816,285	$267,739,296
2	MRK	Merck & Co., Inc.	1,910,947	$245,556,688
3	PFE	Pfizer Inc	7,634,806	$183,846,126
4	SNY	Sanofi	4,136,417	$176,459,547
5	GSK	GSK plc	1,483,198	$77,749,239
6	JNJ	Johnson & Johnson	276,623	$70,253,942
7	NVS	Novartis AG	197,593	$30,966,774
8	OGN	Organon & Co. This page	729,502	$9,877,456

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,877,456	729,502	+5.5%	Shares	Defined	2026-08-14
2026-03-31	$4,142,833	691,625	+14.0%	Shares	Defined	2026-05-15
2025-12-31	$4,348,596	606,499	+46.7%	Shares	Defined	2026-02-11
2025-09-30	$4,415,484	413,435	+3.8%	Shares	Defined	2025-11-14
2025-06-30	$3,856,733	398,423	+77.1%	Shares	Defined	2025-08-13
2025-03-31	$3,349,386	224,942	+6.8%	Shares	Defined	2025-05-15
2024-12-31	$3,141,002	210,523	-0.6%	Shares	Defined	2025-02-10
2024-09-30	$4,051,484	211,787	+3.5%	Shares	Defined	2024-11-14
2024-06-30	$4,237,745	204,722	+5.7%	Shares	Sole	2024-08-19
2024-03-31	$3,641,014	193,671	+8.5%	Shares	Defined	2024-05-15
2023-12-31	$2,574,488	178,536	+50.1%	Shares	Defined	2024-02-09
2021-09-30	$3,899,713	118,930	+2.5%	Shares	Defined	2021-11-12
2021-06-30	$3,509,675	115,984	—	Shares	Defined	2021-08-11
No filing history on record for this holder in this stock.